Endophthalmitis

Br J Hosp Med (Lond). 2019 Jan 2;80(1):C8-C11. doi: 10.12968/hmed.2019.80.1.8.

Authors

Stafford G Sansome¹, Michelle Ting², Saurabh Jain³

Affiliations

¹ Foundation Year 2 Doctor, Department of Neurosurgery, Imperial College Healthcare NHS Trust, London W2 1NY.
² ST6 Ophthalmology Registrar, Moorfields Eye Hospital NHS Foundation Trust, London.
³ Consultant Ophthalmologist, Clinical Director of Ophthalmology, Royal Free London NHS Foundation Trust, London.

PMID: 30592664
DOI: 10.12968/hmed.2019.80.1.8

No abstract available

MeSH terms

Anti-Infective Agents / administration & dosage*
Anti-Infective Agents / therapeutic use
Candidiasis, Invasive / diagnosis
Candidiasis, Invasive / drug therapy
Diabetes Mellitus / epidemiology
Endophthalmitis / diagnosis*
Endophthalmitis / epidemiology
Endophthalmitis / therapy*
Fundus Oculi
Hospitalization / statistics & numerical data
Humans
Immunocompromised Host
Intravitreal Injections
Physical Examination
Risk Factors
Slit Lamp Microscopy
Staphylococcal Infections / diagnosis
Staphylococcal Infections / drug therapy
Streptococcal Infections / diagnosis
Streptococcal Infections / drug therapy
Ultrasonography
Vitrectomy*

Substances

Anti-Infective Agents